NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

DRAGARWALS EYE HOSPITAL ‘s Q3 2024-25 Latest News: Revenue Grows by 25.69% YoY

[fetch_key]

Highlights

🔹 The presented financial data is Standalone to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 25.69 % in the past year, decrease in net sales/revenue by -6.93 %.
🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 143.16 %. Marginal increase in other income during this quarter, up by 1.32%.
🔹 Profit over the Year and quarter: Significant improvement in profitability for DR.AGARWALS EYE HOSPITAL LTD.. Notable increase of 10.17 % in net profit Year to Year, DR.AGARWALS EYE HOSPITAL LTD.’s profitability dropped by -26.5 % Quarter to Quarter.
🔹 EPS over the Year and quarter: EPS increased by 10.15 % Year to Year. EPS decreased by -26.5 % in previous quarter. Analysis needed for shareholder value.

This analytical report on DR.AGARWALS EYE HOSPITAL LTD. stretches beyond conventional financial metrics to include an in-depth exploration of the company’s long-term strategic plans and their alignment with current market conditions. It examines the sustainability of the company’s business model in light of emerging market trends and competitive pressures. The insight provided by seasoned industry analysts adds depth to the evaluation, offering predictions that help in assessing the company’s position and potential movements in its stock price. For investors, this report serves as a crucial tool in understanding the intrinsic value of the company and strategizing their investment moves accordingly.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 75.67 Cr Rs. 102.19 Cr Rs. 95.11 Cr -6.93 % + 25.69 %
Expenses Rs. 55.18 Cr Rs. 72.31 Cr Rs. 69.49 Cr -3.9 % + 25.93 %
Operating Profit Rs. 20.49 Cr Rs. 29.88 Cr Rs. 25.62 Cr -14.26 % + 25.04 %
OPM % 27.08 % 29.24 % 26.94 % -2.3 % -0.14 %
Other Income Rs. 0.95 Cr Rs. 2.28 Cr Rs. 2.31 Cr + 1.32 % + 143.16 %
Interest Rs. 1.83 Cr Rs. 3.67 Cr Rs. 3.85 Cr + 4.9 % + 110.38 %
Depreciation Rs. 6.89 Cr Rs. 9.36 Cr Rs. 10.02 Cr + 7.05 % + 45.43 %
Profit before tax Rs. 12.72 Cr Rs. 19.13 Cr Rs. 14.06 Cr -26.5 % + 10.53 %
Tax % 25.79 % 26.03 % 26.03 % + 0 % + 0.24 %
Net Profit Rs. 9.44 Cr Rs. 14.15 Cr Rs. 10.4 Cr -26.5 % + 10.17 %
EPS in Rs Rs. 20.09 Rs. 30.11 Rs. 22.13 -26.5 % + 10.15 %


Today, we’re looking at DR.AGARWALS EYE HOSPITAL LTD.’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 25.69 %. However, it did see a marginal slip of -6.93 % from the previous quarter. Expenses decreased slightly by -3.9 % quarter-on-quarter, aligning with the annual rise of 25.93 %. Operating profit, while up 25.04 % compared to last year, faced a quarter-on-quarter dip of -14.26 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.14 %, but a shrinkage of -2.3 % sequentially. Other income rose by 1.32 % compared to the last quarter, despite an annual growth of 143.16 %. Interest expenses surged remarkably by 4.9 % from the previous quarter, yet the year-over-year increase remains at a moderate 110.38 %. Depreciation costs climbed by 7.05 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 45.43 %. Profit before tax grew annually by 10.53 % but saw a reduction from the preceding quarter by -26.5 %.
Tax expenses as a percentage of profits increased slightly by 0.24 % compared to last year, with a more notable quarter-on-quarter increase of 0 %. Net profit rose by 10.17 % year-on-year but witnessed a -26.5 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 10.15 % but a quarterly fall of -26.5 %. In summary, DR.AGARWALS EYE HOSPITAL LTD.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 75.67 Cr Rs. 102.19 Cr Rs. 95.11 Cr -6.93 % + 25.69 %
Expenses Rs. 55.18 Cr Rs. 72.31 Cr Rs. 69.49 Cr -3.9 % + 25.93 %
Operating Profit Rs. 20.49 Cr Rs. 29.88 Cr Rs. 25.62 Cr -14.26 % + 25.04 %
Net Profit Rs. 9.44 Cr Rs. 14.15 Cr Rs. 10.4 Cr -26.5 % + 10.17 %
EPS in Rs Rs. 20.09 Rs. 30.11 Rs. 22.13 -26.5 % + 10.15 %


In reviewing DR.AGARWALS EYE HOSPITAL LTD.’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 25.69 % year-on-year growth, although there was a slight dip of -6.93 % from the previous quarter. Expenses rose by 25.93 % compared to the previous year, with a decrease of -3.9 % quarter-on-quarter. Operating Profit surged by 25.04 % annually, and saw a -14.26 % decrease from the last quarter.
Net Profit showed yearly increase of 10.17 %, and experienced a -26.5 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 10.15 % annually, however dipped by -26.5 % compared to the last quarter. In essence, while DR.AGARWALS EYE HOSPITAL LTD. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post